One Global Service Provider
- P/E
- 11.62
Key Fundamentals
MicrocapHealthcare ServicesHealthcarePrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 87.00%
- Debt to Equity
- 0.00
- EPS (TTM)
- ₹37.84
- Book Value
- ₹72.27
- Market Cap
- —
- P/E (TTM)
- 11.62
- P/B
- 6.08
- ROE
- 65.30%
- Dividend Yield
- 0.22%
- EBITDA
- ₹93.50 Cr
- 52W High
- ₹790.00
- 52W Low
- ₹330.00
- Volume
- 0
Peer Comparison
Healthcare › Healthcare Services › Healthcare Service Provider
| ₹2,029.40 | 62.75 | ₹32,036 Cr | 13.58 | 0.26% | 22.30% | 28.00% | ₹2,891 Cr | ₹545 Cr | |
| ₹1,424.60 | 78.15 | ₹14,588 Cr | 15.33 | 0.14% | 18.30% | 20.50% | ₹857 Cr | ₹187 Cr | |
| ₹581.25 | 59.74 | ₹11,437 Cr | 8.03 | 0.88% | 13.60% | 17.80% | ₹1,710 Cr | ₹203 Cr | |
| ₹495.50 | 44.72 | ₹7,723 Cr | 14.25 | 2.90% | 28.40% | 35.40% | ₹876 Cr | ₹176 Cr | |
| ₹622.35 | 148.53 | ₹5,903 Cr | 5.61 | 0.00% | 8.83% | 15.30% | ₹1,053 Cr | ₹85 Cr | |
| ₹333.05 | 48.41 | ₹1,717 Cr | 7.08 | 0.15% | 14.20% | 17.30% | ₹325 Cr | ₹35 Cr | |
| ₹483.05 | 15.84 | ₹1,571 Cr | 1.51 | 0.41% | 10.90% | 12.70% | ₹726 Cr | ₹98 Cr | |
| ₹439.70 | 11.62 | ₹897 Cr | 6.08 | 0.22% | 65.30% | 87.00% | ₹513 Cr | ₹74 Cr | |
| Median 8 companies | ₹538.38 | 54.08 | ₹6,813 Cr | 7.56 | 0.24% | 16.25% | 19.15% | ₹867 Cr | ₹137 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 98/100
Category scores
- Quality
- 68
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 63
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 99
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 75
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 25
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 49
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
5- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 97.2% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 59.0%
Weaknesses
1- Company has high debtors of 159 days.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 7 | 2 |
| Oscillators | Neutral | 1 | 7 | 1 |
| Moving Averages | Strong Bearish | 9 | 0 | 1 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 43.13
- Neutral
- MACD (12,26,9)
- −26.44
- Bullish
- SMA (50)
- 512.77
- Bearish
- SMA (200)
- 563.61
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | Zero base |
|---|---|
| 5Y | +162.44% |
| 3Y | +202.45% |
| 1Y | +238.78% |
| TTM | +163.08% |
Net profit
| 10Y | Zero base |
|---|---|
| 5Y | +103.62% |
| 3Y | +312.13% |
| 1Y | +288.89% |
| TTM | +184.62% |
Operating cash flow
| 10Y | Turned negative |
|---|---|
| 5Y | Turned negative |
| 3Y | Turned negative |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | No sales |
|---|---|
| 5Y | −31.33 pp |
| 3Y | +7.56 pp |
| 1Y | +1.66 pp |
| TTM | +0.64 pp |
Revenue by year
| Mar 2017 | ₹0.00 Cr |
|---|---|
| Mar 2018 | ₹0.00 Cr |
| Mar 2019 | ₹2.00 Cr |
| Mar 2020 | ₹0.00 Cr |
| Mar 2021 | ₹4.00 Cr |
| Mar 2022 | ₹6.00 Cr |
| Mar 2023 | ₹18.00 Cr |
| Mar 2024 | ₹63.00 Cr |
| Mar 2025 | ₹147 Cr |
| Mar 2026 | ₹498 Cr |
Net profit by year
| Mar 2017 | ₹0.00 Cr |
|---|---|
| Mar 2018 | ₹0.00 Cr |
| Mar 2019 | ₹0.00 Cr |
| Mar 2020 | ₹0.00 Cr |
| Mar 2021 | ₹2.00 Cr |
| Mar 2022 | ₹1.00 Cr |
| Mar 2023 | ₹1.00 Cr |
| Mar 2024 | ₹7.00 Cr |
| Mar 2025 | ₹18.00 Cr |
| Mar 2026 | ₹70.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13 | 12 | 15 | 24 | 14 | 19 | 33 | 55 | 88 | 135 | 141 | 134 | 103 |
| Expenses | 11 | 11 | 13 | 19 | 11 | 16 | 29 | 41 | 75 | 109 | 112 | 110 | 84 |
| Operating Profit | 1 | 1 | 2 | 5 | 2 | 3 | 5 | 15 | 13 | 26 | 29 | 24 | 19 |
| OPM % | 11% | 8% | 14% | 22% | 17% | 16% | 14% | 26% | 15% | 19% | 21% | 18% | 19% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 1 | 1 | 2 | 5 | 2 | 3 | 5 | 15 | 13 | 26 | 29 | 24 | 19 |
| Tax % | 25% | 25% | 25% | 26% | 25% | 25% | 27% | 25% | 25% | 25% | 25% | 25% | 25% |
| Net Profit | 1 | 1 | 1 | 4 | 2 | 2 | 3 | 11 | 10 | 20 | 22 | 18 | 14 |
| EPS (₹) | 1.38 | 0.97 | 2.05 | 5.59 | 2.48 | 3.2 | 4.9 | 15.48 | 13.82 | 10.13 | 11.08 | 9.31 | 7.32 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 2 | 0 | 4 | 6 | 18 | 63 | 147 | 498 | 513 |
| Expenses | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 5 | 16 | 53 | 122 | 405 | 414 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 2 | 10 | 25 | 93 | 99 |
| OPM % | — | — | — | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | 14% | — | 68% | 23% | 9% | 15% | 17% | 19% | 19% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| PBT | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 10 | 25 | 93 | 99 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | −3% | −1% | 25% | 26% | 25% | — |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 7 | 18 | 70 | 74 |
| EPS (₹) | −0.14 | −0.11 | −0.13 | 0.27 | 0.38 | −0.42 | 3.28 | 1.48 | 1.94 | 10.01 | 26 | 35.56 | 37.84 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 10% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 20 | 20 |
| Reserves | −5 | −5 | −5 | −5 | −4 | −5 | −2 | −1 | 0 | 7 | 52 | 122 |
| Borrowings | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 2 | 1 | 0 | 1 | 2 | 5 | 17 | 34 | 113 |
| Total Liabilities | 3 | 3 | 3 | 5 | 4 | 3 | 6 | 8 | 13 | 32 | 106 | 254 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 |
| CWIP | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 2 | 1 | 0 | 3 | 5 | 9 | 28 | 104 | 252 |
| Total Assets | 3 | 3 | 3 | 5 | 4 | 3 | 6 | 8 | 13 | 32 | 106 | 254 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 14 | −11 |
| Investing | 0 | 0 | 0 | 0 | 0 | 0 | −1 | −1 | 0 | 0 | 0 | 0 |
| Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 14 | −11 |
| Free Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 14 | −11 |
| CFO/EBITDA | 90 | 162 | 111 | −32 | 141 | 6 | 45 | 38 | 8 | 12 | 67 | 12 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | — | — | — | — | 149 | — | 0 | 242 | 164 | 152 | 134 | 159 |
| Inventory Days | — | — | — | — | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Payable | — | — | — | — | — | — | — | — | — | — | — | 91 |
| Cash Conversion Cycle | — | — | — | — | 149 | — | 0 | 242 | 164 | 152 | 134 | 68 |
| Working Capital Days | — | — | — | — | 37 | — | 149 | 135 | 76 | 57 | 59 | 77 |
| ROCE % | −4% | −3% | −3% | 6% | 9% | −11% | 60% | 18% | 20% | 85% | 56% | 87% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view One Global Service Provider insights
60 extracted metrics across FY11–FY27.
Documents
- General announcements 8 Oct 2026
Frequently Asked Questions about One Global Service Provider
What does One Global Service Provider Ltd do?
Where is One Global Service Provider Ltd (ONEGLOBAL) listed?
Which sector does One Global Service Provider Ltd belong to?
What is the PE ratio of One Global Service Provider Ltd?
What is the 52-week high and low of One Global Service Provider Ltd?
Does One Global Service Provider Ltd pay dividends?
What is the Return on Equity (ROE) of One Global Service Provider Ltd?
Company Information
Incorporated in 1992, One Global Service Provider Ltd is in the business of healthcare services
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/514330.md for One Global Service Provider Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.